Corticosteroid responsive dermatoses

Pruritus Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses Contact dermatitis, atopic dermatitis, nummular eczema, stasis eczema, asteatotic eczema, lichen planus, lichen simplex chronicus, insect and arthropod bite reactions, first- and second-degree localized burns, and sunburns. 

Diflorasone Diacetate Cream For corticosteroid responsive dermatoses... 

Halobetasol propionate is a class I topical corticosteroid, or an ultrapotent corticosteroid according the Stoughton classification system which is widely used in United States. Halobetasol propionate has been approved in the United States for the treatment of corticosteroid-responsive dermatoses. In a number of clinical studies, halobetasol propionate cream and ointment have both been tested against vehicle and compared with other ultrapotent corticosteroids [43]. 

Momethasone furoate has been launched in the US (as an ointment and a cream) for once-daily use in the treatment of corticosteroid responsive dermatoses and as a lotion for the scalp. It has also been launched in many countries for the control and management of persistent asthma in patients aged >12 years. 

Clobetasol propionate Anti-inflammatory agent Relieve inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses Temovate Ointment 0.05... 

Trade names Durezol Epitopic Myser (Sirion) Indications Corticosteroid responsive dermatoses, inflammation and pain associated with ocular surgery Category Corticosteroid, topical Half-life N/A... 

Alclometasone is a topical glucocorticoid with antiinflammatory, antipruritic, and vasoconstrictive properties. It acts by inducing phospholipase A2 inhibitory proteins, thus controlling biosynthesis of potent mediators of inflammation. Alclometasone (0.05% ointment) is a topical adrenocorticoid with antiinflammatory properties that is indicated in inflammation of corticosteroid-responsive dermatoses. 

Used for treatment of corticosteroid-responsive dermatoses with secondary infection. 

Desonide, a topical adrenocorticoid with antiinflammatory properties (0.05% cream, lotion, and ointment), is used as an adjunctive therapy for inflammation in acute and chronic corticosteroid-responsive dermatoses (see also Table 14). 

Topical dexamethasone (gel and cream 0.1%) is indicated in inflammation of corticosteroid-responsive dermatoses. 

Hydrocortisone acetate/urea is a corticosteroid combination. Hydrocortisone depresses formation, release, and activity of endogenous mediators of inflammation as well as modifying the body s immune response. Urea has hydrating and keratolytic properties. They are indicated in the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. 

A mild potency, topical non-fluorinated corticosteroid with low systemic effects. Uses It has been used since 1986 for the treatment of corticosteroid-responsive dermatoses. It is ranked in Group 6 based on potency and has been classified as group D. According to the A-D grouping, patch-test reactions occur six to seven times more frequently within well-defined groups of structurally related chemicals than between corticosteroids of different groups... 

---